Imricor Medical Systems Inc
ASX:IMR
Imricor Medical Systems Inc
ASX:IMR
Price:
1.995
AUD
3.37%
Market Closed
Market Cap:
AU$640.3m
Balance Sheet
Balance Sheet Decomposition
Imricor Medical Systems Inc
Imricor Medical Systems Inc
Balance Sheet Decomposition is not available for
Imricor Medical Systems Inc
Imricor Medical Systems Inc
Balance Sheet
Imricor Medical Systems Inc
Imricor Medical Systems Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
2
|
2
|
5
|
25
|
19
|
6
|
1
|
16
|
20
|
|
| Cash |
2
|
2
|
2
|
5
|
25
|
19
|
6
|
1
|
16
|
20
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
3
|
3
|
2
|
2
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
|
| Total Current Assets |
2
|
2
|
2
|
7
|
29
|
23
|
10
|
4
|
18
|
43
|
|
| PP&E Net |
0
|
0
|
2
|
3
|
4
|
4
|
4
|
3
|
3
|
2
|
|
| PP&E Gross |
0
|
0
|
2
|
3
|
4
|
4
|
4
|
3
|
3
|
2
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
3
N/A
|
2
-7%
|
5
+123%
|
11
+101%
|
34
+219%
|
27
-20%
|
14
-49%
|
8
-39%
|
22
+160%
|
46
+112%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
2
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
12
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
|
| Total Current Liabilities |
1
|
1
|
0
|
1
|
2
|
3
|
2
|
5
|
2
|
17
|
|
| Long-Term Debt |
2
|
2
|
10
|
1
|
1
|
0
|
2
|
8
|
20
|
13
|
|
| Other Liabilities |
3
|
3
|
1
|
1
|
2
|
2
|
2
|
4
|
7
|
4
|
|
| Total Liabilities |
5
N/A
|
6
+19%
|
11
+72%
|
3
-69%
|
5
+36%
|
4
-6%
|
6
+39%
|
17
+176%
|
29
+70%
|
34
+18%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
20
|
25
|
27
|
40
|
53
|
73
|
90
|
113
|
142
|
168
|
|
| Additional Paid In Capital |
16
|
20
|
21
|
47
|
82
|
95
|
97
|
104
|
135
|
179
|
|
| Total Equity |
3
N/A
|
4
-41%
|
6
-43%
|
7
N/A
|
29
+310%
|
22
-22%
|
8
-66%
|
9
N/A
|
7
+16%
|
12
N/A
|
|
| Total Liabilities & Equity |
3
N/A
|
2
-7%
|
5
+123%
|
11
+101%
|
34
+219%
|
27
-20%
|
14
-49%
|
8
-39%
|
22
+160%
|
46
+112%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
93
|
93
|
93
|
93
|
126
|
143
|
151
|
169
|
270
|
321
|
|
Switch to:
Switch to:
See Also
Discover More
